1408 studies found for:    Alzheimer's Disease
Show Display Options
Rank Status Study
21 Completed
Has Results
A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Interferon beta-1a;   Drug: Placebo
22 Unknown  Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Bryostatin for Injection;   Drug: Placebo
23 Completed Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease
Conditions: Alzheimer's Disease;   Central Nervous System Diseases;   Cognition
Interventions: Drug: EVP-6124;   Drug: Placebo
24 Completed Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test
Condition: Alzheimer's Disease
Intervention:
25 Recruiting A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BAN2401 2.5 mg /kg;   Drug: BAN2401 5 mg /kg;   Drug: BAN2401 10 mg /kg;   Drug: Placebo
26 Completed Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient
Condition: Alzheimer's Disease
Intervention: Biological: GSK933776
27 Completed Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia;   Memory Loss;   Cognitive Impairment
Intervention: Drug: ladostigil hemitartrate
28 Completed
Has Results
Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine 5 and 10 cm^2 patch
29 Completed Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: Placebo
30 Completed A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)
Condition: Alzheimer's Disease
Interventions: Other: MRI;   Other: FDG-PET
31 Completed Effect of LY450139 on the Long Term Progression of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: LY450139;   Drug: placebo
32 Completed
Has Results
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine 4.6 mg/24 h (5 cm^2);   Drug: Rivastigmine 9.5 mg/24 h (10 cm^2);   Drug: Rivastigmine 13.3 mg/24 h (15 cm^2);   Drug: Placebo
33 Unknown  Early-onset and Late-onset Sporadic Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Biological: Clinic and neuropsychologic evaluation;   Radiation: MRI;   Procedure: PET;   Biological: Apolipoprotein E genotyping;   Biological: Study of cerebrospinal fluid
34 Recruiting Study of the Safety & Efficacy of Granulocyte-Macrophage Colony-Simulating Factor (Leukine) in the Treatment of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Sagramostim;   Drug: Saline -- placebo comparator
35 Completed Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: Placebo
36 Withdrawn A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia;   Dimebon;   Investigational Drug
Interventions: Drug: PF-01913539 5 mg;   Drug: Placebo
37 Not yet recruiting Evaluation of the Efficacy and Safety of TTP488 in Patients With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TTP488;   Drug: Placebo
38 Recruiting Alzheimer's Disease Genetics Study
Conditions: Alzheimer Disease;   Late Onset Alzheimer Disease;   Dementia
Intervention:
39 Completed Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia
Conditions: Alzheimer's Disease;   Dementia
Intervention: Device: Blood sampling
40 Completed
Has Results
Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline
Condition: Alzheimer Disease
Interventions: Drug: Rivastigmine 5 cm^2;   Drug: Rivastigmine 10 cm^2;   Drug: Rivastigmine 15 cm^2;   Drug: Placebo to 15 cm^2 patch;   Drug: Placebo to 10 cm^2 patch

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years